The Therapeutic Effects of PJ34 [N-(6-Oxo-5,6-dihydrophenanthridin-2-yl) -N,N-dimethylacetamide.HCl], a Selective Inhibitor of Poly(ADP-Ribose) Polymerase, in Experimental Allergic Encephalomyelitis Are Associated with Immunomodulation

G.S. Scott, R.B. Kean, T. Mikheeva, M.J. Fabis, Jon Mabley, C. Szabo, D.C. Hooper

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)1053-1061
Number of pages9
JournalJournal of Pharmacology and Experimental Therapeutics
Publication statusPublished - Sept 2004

Cite this